Combined Multiagent Chemotherapy and Radiotherapy Is Associated with Improved Survival Compared to Chemotherapy Alone in Patients with Non-Operatively Managed Stage II-III Pancreatic Adenocarcinoma. (2022) - Sugumar, K.